Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine and Pramipexole for Language Acquisition in Healthy Subjects
NCT00102856Phase 4Suspended
- Sponsor
- Universitätsklinikum Münster
- Start
- Jan 2005
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of pramipexole, rivastigmine in aphasia, sponsored by Universitätsklinikum Münster. Started Jan 2005; status: suspended.
02
Drugs
pramipexolerivastigmine
03
Conditions
aphasia
Beyond the preview
Go deeper on NCT00102856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102856.